Home
Company overview
Leadership team
Strategy Advisory Board
Partners & Institutions
Therapeutic Areas
Therapeutic Approach
Innovative Lipid Vectors
Pipeline
GAO-3-02 / GAO-11-02
News
Contact
Home
About Us
Company Overview
Leadership team
Strategic Committee
Scientific Advisory Board
Partners & Institutions
Research and development
Therapeutic Areas
Pipeline
GAO-3-02
News
Contact
News
SfN NEUROSCIENCE, SAN DIEGO – NOV. 2022
Read post
GERLI – NOVEMBER 2022
Read post
GAO-3-02 REPORT - PUBLICATION IN EPILEPSIA
Read post
JFE - OCTOBER 2022
Read post
IMBL 22 -JULY 2022
Read post
NEW €2M FUNDING SUPPORT FROM BPIFRANCE - MAY 2022
Read post
DIGITAL RESI - JUNE 2022
Read post
EILAT XVI - MAY 2022
Read post
BIO€QUITY EUROPE - MAY 2022
Read post
BIO EUROPE DIGITAL - OCT. 2021
Read post
GHP - EXCELLENCE AWARD FOR RESEARCH AND INNOVATION
Read post
RESI DIGITAL - SEPT. 2021
Read post
i-LAB 2021 AWARD
Read post
SEED ROUND AND PARTNERSHIP WITH PPRS
Read post
ELLIPSE – INNOVATIONS IN EPILEPSY
Read post
EILAT XV – 2020 – GAOMA THERAPEUTICS TO PRESENT GAO-3-02 DRUG CANDIDATE
Read post
BIO-EUROPE SPRING DIGITALIZED – 2020 – “STARTUP SPOTLIGHT” SELECTED COMPANY
Read post
RESI EUROPE DIGITALIZED - 2020
Read post
SACHS LIFE SCIENCES CEO FORUM - ZURICH, 2020 - "RISING STARS" SELECTED COMPANY
Read post
GRANT OF BOURSE FRENCH TECH EMERGENCE - BPIFRANCE
Read post
